デフォルト表紙
市場調査レポート
商品コード
1225248

生物製剤市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
生物製剤市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生物製剤の世界市場規模は、2022年に3,210億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に8.1%の成長率(CAGR)を示し、2028年までに5355億米ドルに達すると予測しています。

生物製剤は、生物学的製剤とも呼ばれ、生物を原料とする、または生物を構成要素とする疾患修飾性抗リウマチ薬(DMARDs)です。ヒト、動物、鳥、昆虫、植物、微生物に由来するワクチン、血液、血液成分、細胞、遺伝子、組織、アレルゲン、遺伝子組み換えタンパク質など、さまざまな製品が含まれます。これらの製品は、重要なタンパク質の生産を制御し、ヒトのホルモンや細胞を修正し、免疫系を活性化したり抑制したりする物質を生産します。また、生物学的に天然生物細胞内、細胞内の作用の仕方を変化させることもあります。近年、生物製剤は、クローン病、潰瘍性大腸炎、関節リウマチ、その他の自己免疫疾患など、さまざまな疾患や症状の治療に利用され、絶大な支持を得ています。

生物製剤の市場動向

  • 生物製剤の世界市場は、慢性疾患の発生率や診断率が上昇し、高度な診断薬や治療薬の利用が必要になっていることが主な要因となっています。生物製剤は、炎症を引き起こす免疫系の特定の部分をターゲットとして遺伝子工学的に設計されています。各国の政府も、コロナウイルス病(COVID-19)の発症に伴い、ヘルスケア部門を促進し、生物学的製剤の利用可能性を確保するためのイニシアチブをとっています。さらに、科学者や研究者は、生物学的製品の生産性を高めるために、種や発現系を広範囲に調査しています。さらに、さまざまな製薬会社が、関節リウマチやクローン病に対する経口製品の有効性を向上させるための研究開発(R&D)活動を行っています。

主要市場のセグメンテーション

  • IMARC Groupは、世界の生物製剤市場のレポートにおいて、2023年から2028年までの世界、地域、国レベルでの予測とともに、各サブセグメントにおける主要動向の分析を行っています。当レポートでは、供給源、製品、疾患、製造に基づき、市場を分類しています。
  • 供給源別内訳:微生物
  • 哺乳類
  • その他

製品別内訳

  • モノクローナル抗体
  • ワクチン
  • 遺伝子組換え蛋白質
  • アンチセンス、RNAi、分子療法
  • その他

疾患別内訳

  • オンコロジー
  • 免疫系疾患
  • 循環器領域
  • 血液疾患
  • その他

製造別内訳

  • アウトソーシング
  • インハウス

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東・アフリカ地域

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 生物製剤の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 ソース別、市場内訳

  • 微生物
    • 市場動向
    • 市場予測
  • 哺乳類
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 製品別、市場内訳

  • モノクローナル抗体
    • 市場動向
    • 市場予測
  • ワクチン
    • 市場動向
    • 市場予測
  • リコンビナントタンパク質
    • 市場動向
    • 市場展望
  • アンチセンス、RNAi、分子療法
    • 市場動向
    • 市場展望
  • その他
    • 市場動向
    • 市場予測

第8章 疾患別、市場内訳

  • オンコロジー
    • 市場動向
    • 市場予測
  • 免疫疾患
    • 市場動向
    • 市場展望
  • 循環器系疾患
    • 市場動向
    • 市場展望
  • 血液疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 製造業別、市場内訳

  • アウトソーシング
    • 市場動向
    • 市場予測
  • インハウス
    • 市場動向
    • 市場予測

第10章 地域別、市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
図表

List of Figures

  • Figure 1: Global: Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Biologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Biologics Market: Breakup by Source (in %), 2022
  • Figure 5: Global: Biologics Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2022
  • Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2022
  • Figure 8: Global: Biologics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Biologics Industry: SWOT Analysis
  • Figure 89: Global: Biologics Industry: Value Chain Analysis
  • Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million US$), 2023-2028
  • Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million US$), 2023-2028
  • Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Biologics Market: Competitive Structure
  • Table 8: Global: Biologics Market: Key Players
目次
Product Code: SR1423A89_Report

The global biologics market size reached US$ 321.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 535.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn's disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

Biologics Market Trends:

  • The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn's diseases.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on source, product, disease and manufacturing.
  • Breakup by Source:Microbial
  • Mammalian
  • Others

Breakup by Product:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others

Breakup by Disease:

  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others

Breakup by Manufacturing:

  • Outsourced
  • In-House

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.
  • Key Questions Answered in This Report
  • 1. What was the size of the global biologics market in 2022?
  • 2. What is the expected growth rate of the global biologics market during 2023-2028?
  • 3. What are the key factors driving the global biologics market?
  • 4. What has been the impact of COVID-19 on the global biologics market?
  • 5. What is the breakup of the global biologics market based on the source?
  • 6. What is the breakup of the global biologics market based on the product?
  • 7. What is the breakup of the global biologics market based on the disease?
  • 8. What is the breakup of the global biologics market based on the manufacturing?
  • 9. What are the key regions in the global biologics market?
  • 10. Who are the key players/companies in the global biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Source

  • 6.1 Microbial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Mammalian
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Monoclonal Antibodies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Recombinant Proteins
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Antisense, RNAi and Molecular Therapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunological Disorders
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hematological Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Manufacturing

  • 9.1 Outsourced
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 In-House
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis